Arca Biopharma | ABIO - Przychody Ze Sprzedaży





Obroty Zmiana Data
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 10.1B 1.48B 2026-06
Arca Biopharma 0 0 2025-03
Biogen USD 2.74B 490M 2026-06
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cipla INR 71.19B 5.78B 2026-06
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Cytokinetics USD 28.6M 9.25M 2026-06
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Grifols EUR 2B 306.7M 2026-03
Laboratory Of America USD 3.73B 190M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Otsuka Holdings JPY 702.05B 71.71B 2026-06
Pfizer USD 15.03B 530M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06